Granulocyte-macrophage colony-stimulating factor given as an adjuvant to persons not responding to hepatitis B vaccine
- PMID: 9108192
- DOI: 10.1007/BF02113594
Granulocyte-macrophage colony-stimulating factor given as an adjuvant to persons not responding to hepatitis B vaccine
Similar articles
-
Hepatitis B virus vaccine in lymphoproliferative disorders: a prospective randomized study evaluating the efficacy of granulocyte-macrophage colony stimulating factor as a vaccine adjuvant.Eur J Haematol. 2007 Oct;79(4):292-6. doi: 10.1111/j.1600-0609.2007.00912.x. Epub 2007 Jul 26. Eur J Haematol. 2007. PMID: 17655695 Clinical Trial.
-
Granulocyte-macrophage colony-stimulating factor enhances the efficacy of hepatitis B virus vaccine in previously unvaccinated haemodialysis patients.J Viral Hepat. 1999 Sep;6(5):405-9. doi: 10.1046/j.1365-2893.1999.00180.x. J Viral Hepat. 1999. PMID: 10607257 Clinical Trial.
-
The safety and efficacy of GM-CSF as an adjuvant in hepatitis B vaccination of chronic hemodialysis patients who have failed primary vaccination.Clin Nephrol. 2000 Aug;54(2):138-42. Clin Nephrol. 2000. PMID: 10968690 Clinical Trial.
-
Old and new adjuvants for hepatitis B vaccines.Med Microbiol Immunol. 2015 Feb;204(1):69-78. doi: 10.1007/s00430-014-0375-9. Epub 2014 Dec 19. Med Microbiol Immunol. 2015. PMID: 25523196 Review.
-
A prophylactic hepatitis B vaccine with a novel adjuvant system.Vaccine. 2001 Mar 21;19(17-19):2400-3. doi: 10.1016/s0264-410x(00)00462-x. Vaccine. 2001. PMID: 11257368 Review.
Cited by
-
MUC1-specific immune therapy generates a strong anti-tumor response in a MUC1-tolerant colon cancer model.Vaccine. 2007 Feb 19;25(9):1607-18. doi: 10.1016/j.vaccine.2006.11.007. Epub 2006 Nov 16. Vaccine. 2007. PMID: 17166639 Free PMC article.
-
A role for granulocyte-macrophage colony-stimulating factor in the regulation of CD8(+) T cell responses to rabies virus.Virology. 2012 May 10;426(2):120-33. doi: 10.1016/j.virol.2012.01.025. Epub 2012 Feb 16. Virology. 2012. PMID: 22341782 Free PMC article.
-
Granulocyte-macrophage colony-stimulating factor as an immune-based therapy in HIV infection.J Immune Based Ther Vaccines. 2005 May 18;3(1):3. doi: 10.1186/1476-8518-3-3. J Immune Based Ther Vaccines. 2005. PMID: 15904525 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical